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“You can't stop the waves, but you can learn to surf.” 
 
Jon Kabat-Zinn, Full Catastrophe Living 
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Abstract 
The purpose of this study was to explore Mindfulness based cognitive therapy (MBCT) as an 
adjunct clinical intervention for the treatment of refractory anxiety patients in a randomized 
controlled clinical trial. Furthermore, the current study examined whether and how the five 
facets of mindfulness are related to changes in residual anxiety symptoms. The study was 
performed in 15 patients from the mental health organization of PsyQ.  They were randomly 
allocated to either the MBCT group or the treatment-as-usual (TAU) group, both with the 
duration of 8 weeks. Patients completed internet-based questionnaires assessing the severity 
of anxiety symptoms and mindfulness at baseline, halfway and at the end of the treatment. 
Results showed significant decreases of residual anxiety symptoms in the MBCT group and 
TAU group. This study also found significant improvements of all mindfulness facets during 
the MBCT course. Regression analysis revealed that a strong trend was found between 
changes in the non-judging facet and decreased residual anxiety symptoms. These results 
support the notion that MBCT could be a promising adjunct clinical intervention in treating 
refractory anxiety patients. Future randomized controlled studies are needed to replicate these 
results using larger, more representative samples of the population and a longer follow up-
period. 
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1. Introduction 
In the Netherlands, anxiety disorders have the highest incidence (3.1%) and life time 
(19.3%) and past year (12.4%) prevalence of all psychiatric disorders (Schoemaker, van 
Balkon, Gool, Gommer & Poos, 2010). Anxiety disorders are often comorbid to mood and 
somatic disorders (Brown, Campbell, Lehman, Grisham, & Mancill, 2001). In addition 
anxiety disorders are often associated with greater functional impairments and a more severe 
and chronic course (Klein Hofmeyer-Sevink et al., 2012) which lead not only to an increase of 
a person’s burden but also to high societal costs (Andlin-Sobocki, Jonsson, Wittchen & 
Olesen, 2005). This emphasizes the need for effective treatments.  
Cognitive-behavioral therapy (CBT) is widely acknowledged as the treatment of first 
choice for anxiety disorders (van Balkom, van Dyck & Schoemaker, 2010; Clark, 2011). The 
goal of CBT is to learn patients how to identify and modify unrealistic and negative thought 
patterns (Hamamci, 2006). Meta-analyses show that CBT is effective in the treatment of 
anxiety disorders in randomized controlled trials and in the clinical setting (Hofmann & 
Smits, 2008; Stewart & Chambless, 2009). Approximately 38%-77% of the anxiety patients 
respond to CBT (Hofmann, Asnaani, Vonk, Sawyer & Fang, 2012). This percentage indicates 
that not all individuals with anxiety disorders benefit from CBT.  The current 
multidisciplinary clinical guidelines (Trimbos Institute, 2003) do not prescribe further 
treatment options for this substantial group of treatment refractory anxiety patients who are 
resistant to treatment.  The development of alternative treatment options for this group is 
therefore warranted.  
In the last decade, research investigating mindfulness and mindfulness-based 
interventions has increased tremendously (Baer, 2003; Chiesa & Serretti, 2010). 
Mindfulness has been defined as “the awareness that emerges through paying attention on 
purpose, in the present moment, and nonjudgmentally to the unfolding of experience moment 
by moment’’(Kabat-Zinn, 2003, p.145). Increasing evidence suggests the potential usefulness 
of mindfulness-based interventions for the treatment of a large number of mental disorders 
(Lynch, Trost, Salsman & Linehan, 2007; Chiesa & Serretti, 2010). 
 The most widely utilised mindfulness-based intervention is Mindfulness based 
cognitive therapy (MBCT), an 8 week skills training group program. MBCT is based upon 
integrating aspects of Cognitive behavioural therapy for major depression (MD) (Beck, Rush, 
Shaw & Emery, 1979) and the theoretical framework of information processing theories 
(Teasdale, Segal, Williams & Mark, 1995) with components of the Mindfulness-based stress 
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reduction program developed by Kabat-Zinn (Kabat-Zinn, 1990). MBCT was originally 
designed to teach patients in remission from recurrent MD to become more conscious of, and 
to relate differently to, their negative thoughts, feelings, and bodily sensations with the aim to 
reduce recurrence and relapse of MD. An example includes not to try to change thoughts but 
emphasizes that someone needs to learn to accept their thoughts as thoughts instead of fixed 
realities (Roemer & Orsillo, 2002). The original program teaches skills that allow individuals 
to disengage from maladaptive emotion regulation strategies (control, avoidance, or 
suppression) as a way to reduce future risk of relapses and recurrences of MD (Segal, 
Williams & Teasdale, 2002; Hayes, 2004; Williams, 2010). MBCT approximately halved 
rates of relapse and recurrence compared with patients who continued with treatment as usual 
(TAU) (Teasdale et al., 2000). MBCT has also shown to be effective in treating patients with 
residual depressive symptoms (Kingston, Dooley, Bates, Lawlor & Malone, 2007). 
Although initially designed for reducing recurrence and relapse of major depression, 
preliminary data suggest that MBCT may be helpful for improving anxiety symptoms in 
patients with anxiety disorders (Hofmann, Sawyer, Witt & Oh, 2010). Calculated effect size 
estimates from this meta-analysis showed that the mindfulness interventions were associated 
with more significant improvements in symptoms of anxiety (Hedges’ g = 0.97). After a 3-
month follow-up period, therapeutic gains were maintained. Promising results of reducing 
anxiety during mindfulness based interventions were found in the short- and long-term 
(Miller, Flecther & Kabat-Zinn, 1995; Evans et al.,2008) as well as for stand-alone and 
integrated mindfulness-based interventions (Hedges’ g = 1.08) (Vollestad, Nielsen & Nielsen, 
2012).. Finucane & Mercer (2006), showed that after CBT in primary care the use of MBCT 
for patients who continue to report anxiety symptoms was beneficial to majority of patients in 
their study. Three months after the MBCT course had ended more than half of the anxiety 
patients were still using the mindfulness skills. A randomised clinical trial comparing MBCT 
to TAU in people with health anxiety reported that the individuals in the MBCT group scored 
significantly lower on the anxiety scores than the TAU group (McManus, Surawy, 
Muse,Vazquez-Montez, & Williams, 2012). 
The importance of an intervention such as MBCT that in addition to standard 
treatments, could enhance treatment outcomes and optimize standard care can be best 
understood if someone considers that anxiety disorders are usually characterized by a chronic 
course (Klein Hofmeyer-Sevink et al., 2012) are related to a high societal costs (Andlin-
Sobocki, Jonsson, Wittchen & Olesen, 2005) and are only partially responsive to current 
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treatments (Hofmann, Asnaani, Vonk, Sawyer & Fang, 2012). Taking into consideration such 
issues, the importance of an intervention like MBCT, which could improve current treatment 
options like CBT by reducing residual symptoms becomes obvious, especially because 
MBCT has also the advantage of a group format that allows greater accessibility in a clinical 
setting (Chiesa & Serretti, 2011). 
Relatively, little is known about how MBCT works. An interesting question that can 
be raised is whether mindfulness skills indeed improve during an MBCT course, and if so, 
whether these improvements are related to a decrease in residual anxiety symptoms. So far 
only a few studies have investigated this interesting subject. The results showed that 
mindfulness is indeed a skill that can be learned (Carmody & Bear, 2008; Brown & Ryan, 
2003). According to Baer et al., (2006) mindfulness can be best examined as a multi-faceted, 
five-factor construct. Through exploratory factor analysis five distinct facets of mindfulness 
emerged: observing, describing, acting with awareness, non-judging of inner experience and 
non-reactivity to inner experience. Observing means that you become aware of or attending to 
internal (cognitions) and external (noises, smell) stimuli. Describing refers to categorize your 
internal experiences with words. Acting with awareness means that you focus on your current 
activities instead of doing everything on autopilot. Non-judging of internal experience means 
that you abstain from an evaluation of thoughts and feelings. Non-reactivity to inner 
experience means that you allow thoughts and feelings to come and go without evaluating 
them.  
 The facets of mindfulness and how they relate to psychological symptoms has also 
been explored. Baer et al. (2008) found acting with awareness, non-judging and observing to 
be significant predictors in decreasing psychological symptoms. De Bruin et al. (2012) found 
that non-judging, non-reactivity, and acting with awareness were significant predictors in 
decreasing psychological symptoms. In only one study they investigated which of the 
mindfulness facets specifically predicted a decrease in anxiety symptoms. They found that 
non-judging predicts lower levels of anxiety (Cash & Whittingham, 2010). According to 
Woodhead et al. (2013) there is a difference in the way in which mindfulness facets are used 
by different populations (e.g. clinical sample or community sample). Above-noted studies 
were conducted only in non-clinical populations. Investigating facets of mindfulness in a 
clinical population is necessary to improve the understanding of the specific skills that are 
developed through MBCT and how these are related to psychological adjustment. Improved 
knowledge of the relationship between specific facets of mindfulness and residual anxiety 
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symptoms may improve the development of mindfulness as an (complementary) intervention 
(Cash & Wittingham, 2010).  
 Using a randomized controlled design (RCT), we will compare MBCT with a TAU 
group. The TAU group is an after-care treatment where refractory anxiety patients learn skills 
(practice new coping skills and engage in daily activities) to prevent relapse.The purpose of 
the current study was 1) to investigate whether MBCT is more effective in treating/decreasing 
anxious symptoms in treatment refractory anxiety patients than a TAU group using a 
randomized controlled design and 2) to investigate the (improved) changes of mindfulness 
facets during the MBCT course, and if so, which facets (as measured by the FFMQ) during 
the MBCT is/are the most important predictor(s) of symptom reduction in anxiety. The 
following specific hypotheses are tested in the current study. 
 
Hypothesis 1: Since the empirical literature have shown positive effects of 
mindfulness based interventions on anxiety symptoms (Hofmann, Sawyer, Witt & Oh, 
2010; Miller, Flecther & Kabat-Zinn, 1995; Evans et al.,2008; Finucane & Mercer, 
2006; McManus et al., 2012), we expected that participants in the MBCT condition 
would show significant decreases in severity of anxiety symptoms, while no such 
changes were expected in the TAU group.  
Hypothesis 2: We expected that patients report an increase of all five mindfulness 
facets (Carmody & Bear, 2008).  
Hypothesis 3:  Because of the promising, but preliminary results of facets that were 
predictors of psychological symptoms (Baer et al., 2012; de Bruin et al., 2012) we 
expected that non-judging (Cash & Whittingham, 2010) will predict a decrease in 
anxiety symptoms in the MBCT group. Observing, describing, act-awareness and non-
reactivity will not predict a decrease in anxiety symptoms. 
 
2. Method 
2.1 Study population and design 
Patients from age 18 with residual anxiety symptoms were included if, after 
conclusion of treatment according to the clinical guidelines, they still fulfilled the criteria for 
this Axis-I anxiety disorders according to the Mini-International Neuropsychiatric Interview 
(MINI; Sheehan et al., 1998a, 1998b).  
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To optimize the external validity of the study, patients with comorbid Axis-I or Axis-II 
disorders in addition to their primary Axis-I Anxiety disorder, were also be included in the 
study. Other inclusion criteria were a willingness to refrain from treatment or counselling 
more frequently than once a month outside the context of the present trial and to engage in 
homework between sessions in both conditions. The use of antidepressant medication or 
benzodiazepine was permitted, under the condition that the medication dose has been stable 
for at least three months before inclusion and patients were willing to keep a dosage on a 
constant level during the active phase of the trial.   
Exclusion criteria were an primary Axis-I diagnoses of substance abuse or 
dependence, suicidality, presumed autism spectrum disorder and the presence of psychotic 
symptoms, low intelligence (<85) and problems with Dutch language because these 
conditions could interfere with the measurement and treatment procedures and/or suggested 
an immediate need for alternative interventions. Also patients who already received 
mindfulness based treatment were excluded from the study.  
Previous pre-post comparison of mindfulness interventions in anxiety patients found a 
significant medium effect size of g = 0.50 (Hofmann, Sawyer, Witt & Oh, 2010).To find 
similar effects (with power of 0.80 at an α-level of 0.05), we had to enrol at least 64 
participants in each group to detect a possible significant effect.  However, in this study only 
the first preliminary results are presented, wherefore the outcomes are based on a smaller 
sample size (N=15). The study will continue until the total of 128 patients is achieved.  
The study was performed at PsyQ (Parnassia Bavo group), a large urban ambulatory 
mental health organization in the Hague at the department of anxiety disorders and had 
received full approval by The Dutch Medical Ethical Committee (METC) of LUMC Leiden. 
The design of the study was a two-group (MBCT, TAU) randomized controlled clinical trial 
with repeated measurements at baseline (T0), mid-test (T1) and post-test (T2).  
 
2.2 Measurements  
 Mini-International Neuropsychiatric Interview (MINI; Sheehan et al., 1998a,1998b). 
The MINI was used to obtain DSM-IV diagnoses. The validation of the Dutch translation of 
the clinician rated (CR) version of the MINI (van Vliet & de Beurs, 2007) against the 
Structured Clinical Interview DSM-III-R-patient version  (SCID-P) and the Composite 
International Diagnostic Interview for ICD-10 (CIDI) showed good to very good kappa values 
(Sheehan et al., 1998b). 
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 Beck Anxiety inventory (BAI) (Beck, Epstein, Brown, & Steer, 1988). The BAI is a 
self-report questionnaire which consists of 21 items, each describing a common symptom of 
anxiety over the past week on a 4-point likert scale ranging from 0 to 3 (total score is 63). The 
scale has good internal consistency (0.92) and convergent validity (0.51) and discriminates 
between depression and anxiety. Test-retest reliability also appeared to be sufficient (0.75).  
 Five Facet Minfulness Questionnaire (FFMQ-NL) (Muskens & Kamphuis, 2008). 
This 39 item questionnaire assesses five core dimensions of mindfulness on a five point likert 
scale, including observing (8 items), describing (8 items), acting with awareness (8 items), 
non-judging (8 items) and non-reacting (7 items). Validity and reliability have been tested and 
are good. The FFMQ-NL shows good psychometric properties that confirm the findings of the 
original English language version of the FFMQ (de Bruin et al., 2012). In this study, 
mindfulness will be measured using the Dutch version of the FFMQ (Muskens & Kamphuis, 
2008). The FFMQ-NL is after a MBCT associated with improvements in symptomatology (de 
Bruin et al., 2012). 
 
2.3 Procedure  
Before randomization to the trial, patients have received treatment for their anxiety 
disorder according to the clinical guidelines (Trimbos Instituut, 2003). During this treatment 
period, three monthly Routine Outcome Measurements (ROM) was used to evaluate treatment 
progress. Patients who showed not enough improvement on the basis of the questionnaires or 
by the clinical judgement of their therapist were then assigned by their therapist to one of the 
trained research assistants. The assistant then informed the patient about the study by 
telephone. Another way to recruit patients was to scan their patient files (out of the Electronic 
Patiënt System)  for the in- and exclusion criteria. If the patient met the criteria, the research 
assistant first needed permission from the patients’ therapist before contacting them.  After a 
week of consideration the patients who wanted to participate were invited for a research 
interview including the Mini-International Neuropsychiatric Interview (MINI) (Sheehan et al. 
1998). The interviews were used to assess inclusion and exclusion criteria again and were 
conducted by a psychologist in training, supervised by an experienced psychologist. 
Participants were than randomised by a True Random Number Generator programme (Haahr 
& Haahr, 1998). Approximately one month before the start of the interventions the 
participants had an introductory meeting with the practitioners of the MBCT en TAU group to 
get to know each other and for further information about the intervention. At each assessment 
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(baseline (T0), midtest (T1) and posttest (T2)), symptom questionnaires were administered, 
through an online survey system called Qualtrics.  
MBCT was offered according to the protocol of Teasdale, Segal, and Williams (2003). 
MBCT, adapted for anxiety disorders, has been provided in eight weekly two-hour group 
sessions consisting of a maximum of eight patients suffering from different anxiety disorders 
which is in line with the transdiagnostic starting point of MBCT. During these sessions, 
different skills were taught to help patient to become more aware and to relate differently to 
their anxious thoughts, feeling and sensations (Teasdale et al., 2000). Participants were 
expecting to engage in homework between sessions, which could consist of up to an hour of 
mindfulness practice and exercises each day. Each MBCT course was provided by two 
experienced therapists who received formal MBCT training and weekly supervision by a 
senior licensed psychotherapist with formal training and extensive experience in delivering 
MBCT.  The MBCT course was covering the following topics. In session one and two 
patients were taught to become more aware of the habitual ‘automatic pilot’ way in which 
information is processed and the distractibility of the mind by automatic thoughts and 
feelings. Session three is devoted to how focusing on breathing can be helpful to stay in the 
here-and-now. Session four and five focussed on the counterproductive effect of avoiding and 
escaping negative thoughts and feelings compared to an accepting and tolerating stance. In 
session six, patients were taught to disengage from negative thoughts by labelling them as 
thoughts instead of facts. Sessions seven en eight focussed on relapse prevention. 
 Patients in de TAU condition were offered a form of supportive follow-up care, which 
is routine procedure in most mental health care programs. Follow-up care was also provided 
in eight weekly two-hour sessions consisting of a maximum of eight patients. The treatment 
contains different components like pinpoint the triggers of anxiety, learning new coping 
strategies to deal with problems encountered in daily life and to increase self-efficacy. 
Patients were asked to complete individual homework assignments on a daily basis (for 
example to practice new coping skills and engage in daily activities). Follow-up care was 
given by experienced cognitive behavioural therapists. 
The format of the MBCT and TAU group was as similar as possible to decrease the 
confounding non-specific factors, like participating in structured group therapy, equal number 
of trainers/patients in each group and the same homework intensity.  
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2.4 Statistical Analyses 
Independent sample t-test and Fisher’s exact tests were conducted to examine differences 
between the two groups at baseline on demographic variables and outcome measures. To test 
hypothesis 1 changes of mean scores in anxiety and mindfulness from pre- to post treatment 
were analysed. In addition a series of two-way [2 (Groups: TAU and MBCT) × 3 (pre (T0), 
mid (T1), posttest(T2))] ANOVA with repeated measures was conducted on the dependent 
variable (Scores: BAI), with Group as a between-subject and Session as a within-subject 
variable. To determine whether there is a difference in anxiety level between the two 
treatments at the start of treatment (T0), an independent t-test was conducted.  
For hypothesis 2 five different graphs were plotted to see how the five facets of 
mindfulness developed over time per patient in the MBCT group. A paired t-test was 
performed to examine the change of the five mindfulness facets over time (p<0.05). To test 
hypothesis 3, a correlation analysis was used to examine whether changes in the five facets of 
mindfulness are related to changes in anxiety. Change scores were calculated (T2-T0) and 
residual plots of statistically significant correlations were inspected for regression 
assumptions. Finally, with the change score of the significant mindfulness facets (independent 
variables X) and the change score of anxiety symptoms (dependent variable Y,) (as measured 
by the BAI) regression analyses were conducted. Unfortunately, because of the small sample 
size it was not possible to run a multiple regression analysis for each of the mindfulness facets 
at the same time. Therefore, separate regression analysis were conducted. This analysis was 
controlled for pre-intervention scores of mindfulness facets and anxiety. All analyses were 
conducted using SPSS 21. 
 
3. Results 
Patients were recruited from March 2014 till September 2014. Of the 635 patients who 
were assigned by their therapist or screened on basis of their patient file, 522 did not meet the 
inclusion criteria. During telephone screening, the main reasons for people not to participate 
were (a) other commitments (work, school) that would have interfered with participation in 
the study (N=26),  not interested after hearing more about the study (N=20) and the research 
assistant was unable to contact for a telephone interview after their initial contact (N=3). The 
remaining 64 patients were assessed for eligibility. Through interviewing (MINI), a further 15 
were found not to be eligible (substance abuse N=3, medication dose not stable for at least 
three months N=6, not fulfilled the criteria for this Axis-I anxiety disorders N=6). This left a 
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sample of 49 patients to be randomized to the MBCT group (N=22) and the TAU group 
(N=27). After randomization, eleven patients from the MBCT group and eight patients from 
the TAU group, dropped out because they decided not to start with the intervention (physical 
problems N=2, no availability to school/work/family N=14, unknown reasons N=2, 
worsening of symptoms N=1).  36% of the patients in the MBCT group and 58 % in de TAU 
group did not completed all measurements. Full data sets were, therefore, available for N = 7 
participants allocated to MBCT and N = 8 to TAU. Figure 1 provides an overview of the flow 
of participants. 
 The sample consisted of 7 women and 8 men. Most of the patients (80%) were of 
Dutch nationality highly educated (60%). The diagnosis of panic disorder was the most 
frequent anxiety disorder in the total sample. Table 1 shows an overview of patients’ baseline 
characteristics. There were no significant differences at baseline between the MBCT group 
and the TAU group for any of the demographic variables and outcome measurements. 
Patients who did not complete mid- and post assessments (N=13) did not differ from patients 
that completed the mid- and post assessments (N=15) on baseline BAI scores, FFMQ scores 
and age (p > 0.05). However, significantly more women did not completed the mid-and post 
assessments (Fisher's exact test, p = 0.006).  
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Excluded N= 522 
1=Not ready for follow up care 
N= 315 
2= Not fulfill criteria of Axis I 
N=70 
3=Already participated in MBCT 
or TAU: N=35 
4=Substance abuse: N= 27 
5=No dutch speaking: N= 13 
6=Psychosis: N= 12 
7=Autism: N= 14 
8=low intelligence (<85): 7 
9=No permission of therapist: N= 
22 
10=Suicidal: 7 
11=Age (<18): N= 1 
 
Assigned by therapist or patient file screening: 
N= 635 
Randomized: 
N=49 
Allocated to TVP: 
N=27 
Received TVP: 
N=19 
Analysed: N= 8 
 
Excluded from analysis: 
N= 4 (  N=3, completed 
two measurements (T0 & 
T2 instead of three (T0, T1, 
T2)  N=1 participated in 
both treatment groups 
Allocated to MBCT: 
N=22 
Received MBCT: 
N=11 
 
Analysed: N= 7 
 
Excluded from analysis: 
N= 1 ( participated in 
both treatment groups) 
 
Completers T2: N=12 
Drop out: 
N=19 
 
Completers T2: N=8 
Reason for dropping-out:  
1. No availability due to 
work/school/family/childre
n: N=14 
2. Physical sickness: N=2 
3. Worsening of symptoms: 
N=1 
4. Unknown: N=2 
Did not receive 
TVP: 
 N=8 
 
Did not receive 
MBCT:  
N=11 
 
Completers T0: N=17 Completers T0: N=11 
Completers T1: N=14 Completers T1: N=10 
Initial contact by telephone: 
N= 113 
 
Assessed for eligibility (MINI): 
N=64 
Excluded N= 49 
- Refused to participate 
(N=20) 
- Other commitments 
that would have 
interfered (work, 
school) (N=26) 
- Unable to contact 
them (N=3) 
 Excluded N= 15 
Not meeting 
inclusion criteria 
 
Figure 1. Flowchart of the study: Mindfulness Based Cognitive Therapy for treatment 
refractory anxiety patients 
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Table 1.  
Baseline characteristics of the total sample (N=15) 
  N % 
Ageᵃ Mean (SD) 43.53 (11.84)  
 Range 27-68  
Genderᵇ Female 7 46,7% 
 Male 8 53,3% 
Educationᵇ Low 2 13.3% 
 Middle 4 26,7% 
 High 9 60,0% 
Diagnosis Panic disorder 
Generalized anxiety disorder 
Obsessive compulsive  disorder 
Anxiety not otherwise specified 
8 
          2 
3 
2 
53,3% 
 13,3% 
 20,0% 
 13,3% 
ᵃ No significant differences between MBCT and TAU (t-test with P<0.05) 
ᵇ No significant differences between MBCT and TAU (Fisher’s exact test with P<0.05) 
Note: Total percentages may nog add up to 100 % due to rounding errors. 
 
Table 2 shows the mean scores of the studied variables anxiety and mindfulness in the 
MBCT group and the TAU group at baseline, midtest and posttest. The mean score of anxiety 
in the MBCT group decreased from 19.6 (moderate anxiety) before the intervention to 9.4 
(mild anxiety) after the intervention. In addition, the mean score of anxiety in the TAU group 
decreased from 33.5 (severe anxiety) before the intervention to 23.8 (moderate anxiety) after 
the intervention. Considering the mindfulness variable, the MBCT group mean score 
increased from 21.8 before the intervention to 27.2 after the intervention. Finally, the TAU 
group mean score increased a little from 23.4 before the intervention to 24.2 after the 
intervention. 
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Table 2. 
Mean scores of anxiety and Mindfulness in the MBCT group and TAU group at baseline, mid-test and 
post-test. 
 MBCT   TAU   
Variable, 
Mean ± SD 
Pre-test Mid-test Post-test Pre-test Mid-test Post-test 
Anxiety 19.6±11.1 13.4±11.5 9.4±10.6 33.5±13.9 23.8±11.9 23.8±9.1 
Mindfulness 21.8±4.5 24.9±4.5 27.2±4.9 23.4±2.7 24.2±4.7 24.2±3.8 
       
A series of two-way [2 (Groups: TAU and MBCT) × 3 (pre (T0), mid (T1), 
posttest(T2))] ANOVA with repeated measures of BAI scores with group as a between-
subject and Session as a within-subject variable was conducted. Mauchly’s test indicated that 
the assumption of sphericity had been violated, χ²(2) = 6.21, p = 0.045, therefore degrees of 
freedom were corrected using Greenhouse-Geiser estimates of sphericity (Ԑ = 0.712). The 
results showed a signiﬁcant change over time for both groups F(1.43, 18.52) = 8.13; p = 
0.006. This change was noted to be linear, where BAI scores decreased from pre-treatment to 
post-treatment F(1, 13) = 9.50; p = 0.009 (Figure 2). No signiﬁcant interaction between group 
and time of testing was observed F(1.43, 18.52) = 0.36; p = 0.633. 
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Figure 2. Changes in BAI scores for the MBCT group and TAU group from baseline to post-
treatment. 
 
An independent sample t-test was conducted to compare the differences between the 
level of anxiety between de MBCT group and TAU group at pre-test (T0). This independent t-
test showed that at the beginning of the treatment patients in the TAU (M = 33.50, SE = 4.20)  
group had higher levels of anxiety than patients in de MBCT group (M = 19.57, SE = 4.90).  
This difference was not significant t(13) = -2.13, p = .083. This results suggest that there was 
no significant difference in the level of anxiety between the two groups at the start of the 
treatment.  
Regarding to the second hypothesis, five different explanatory graphs were plotted to 
see how the five mindfulness facets developed over time per patient (N=7) in the MBCT 
group (Figure 3). A noticeable difference between the mindfulness facets, is that only the non-
reactivity facet improved in all the patients from pre-to post treatment.  The other facets did 
not improve in all patients from pre- to post treatment. Despite the fact that some of the facets 
did not improve in all patients a paired t-test showed that all mindfulness facets changed 
significantly from pre- to post treatment (P<0.05). Effect sizes were moderate.  
18 
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Figure 3. Changes in mindfulness facets scores per patient for the MBCT group from baseline  
to post-treatment. 
 
The correlations between the change score of mindfulness facets and the change score 
of anxiety over the course of the MBCT intervention are shown in Table 3. Results showed 
that an increase of the mindfulness facets non-reactivity and non-judging were significantly 
related to lower anxiety symptoms. Plots for both analysis suggested that the model 
assumptions (normality, homoscedasticity and linearity) were not violated. Two separate 
linear regressions were calculated regarding to the third hypothesis, after controlling for the 
pre-intervention scores of the two facets and anxiety, to predict changes in anxiety symptoms 
based on the changes in non-judging facet and changes in the non-reactivity facet. A strong 
trend was found according to the non-judging facet (F(1,5) = 4.154, p = 0.06), with an R² of 
.641. Patients predicted changes in anxiety symptoms were equal to -0.955-1.398. Patients 
anxiety symptoms decreased 1.398 points for each improved score (+1) of the non-judging 
facet. There was no significant regression equation found between changes in the non-
reactivity facet and changes in anxiety symptoms (F(1,5) = 2.644, p = 0.165). 
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Table 3.  
Correlations of the variables in the analysis.  
Variable 2 3 4 5 6 
1. Anxiety -.360 -.168 -.105   -.674** -.588* 
2. Observing --  .084  .505 .119    .699** 
3. Describing  --    .605* .297    .637** 
4. Acting with 
awareness 
  -- .317    .702** 
5. Non-judging    --  .554* 
6. Non-reactivity     -- 
Note. * p≤0.05, **p≤0.01 
4. Discussion 
The aim of this exploratory randomized controlled trial was to investigate whether 
MBCT can successfully reduce symptoms of anxiety in treatment refractory patients and to 
examine whether and how changes in mindfulness are associated with symptom reduction in 
anxiety in the MBCT group. Previous studies have shown positive effects of mindfulness 
based interventions on anxiety symptoms (Hofmann, Sawyer, Witt & Oh, 2010; Evans et 
al.,2008; McManus, Surawy, Muse,Vazquez-Montez, & Williams, 2012). Consistent with 
these studies, our results showed that treatment with MBCT significantly reduced anxiety 
symptoms from moderate to mild levels from pre-treatment to post-treatment. However, there 
was no significant advantage of MBCT over TAU. This is in contrast to previous studies 
showing the MBCT group scored significantly lower on anxiety scores than the TAU group 
(McManus, Surawy, Muse,Vazquez-Montez, & Williams, 2012; Hofmann, Sawyer, Witt & 
Oh, 2010). An independent t-test showed that there was no significant difference in the level 
of anxiety between the two groups at the start of the treatment. This finding is in addition to 
the detected significant difference in anxiety level at post-treatment consistent with the idea 
that treatment options like MBCT, in addition to CBT, could enhance treatment outcomes 
differently from pre- to post treatment. Caution in interpreting these findings is important due 
to the small sample size.  
 Furthermore, this study wanted to know if mindfulness indeed improved during a 
MBCT course. Explanatory graphs showed that only the non-reactivity facet improved in all 
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patients during the MBCT course. Despite the fact that not all patients increased their 
mindfulness skills significant improvements were found for all the mindfulness facets. This 
finding was consistent with previous studies who showed that mindfulness is a skill that can 
be learned during the course of a mindfulness-based intervention (Carmody & Bear, 2008; 
Brown & Ryan, 2003). 
 Finally,  this study investigated whether an increase of mindfulness skills predicted a 
decrease in residual anxiety symptoms. Such information is relevant for clinical practice, as 
the results suggest that the enhancing effect of MBCT on anxiety symptoms is related to 
becoming more mindful. A strong trend was found between the non-judging facet and anxiety 
symptoms indicating that an increase in the non-judging facet was related to a decrease of 
residual anxiety symptoms. This finding was inconsistent with the previous study of Cash & 
Wittingham (2010) who did find a significant effect between the non-judging facet and 
residual anxiety symptoms. The discrepancy is most likely caused by the small sample size. A 
larger sample will increase the change of finding possible significant differences.  
The present study has several limitations. First of all, and most importantly, this study 
is based on a small sample of patients. That leads to interpreting these findings only as 
explorative results. The small sample size was largely due to the difficult population of 
patients with residual symptoms. This specific patient population led to difficulties in the 
patient recruitment and a high drop-out rate. Because this group of patients already received 
one or more interventions, a large number was not motivated enough to try other treatment 
options. Therefore, it was challenging to recruit patients that were willing to participate and 
also meet the in- and exclusion criteria. The main reason for the high drop-out rate was the 
psychosocial and environmental problems (axis IV) patients have to deal with as a result of 
their persistent anxiety symptoms such as educational problems, work problems, psychical 
complaints and/or private problems. Patients reported that they wanted to shift their priorities 
to these important problems in life instead of starting a new treatment. One other reason for 
patients to drop-out was because of the length of the questionnaires (patients did not want to 
fill out the questionnaires because they were too long). The small sample size may have 
impacted the ability to detect differences that may or may not have existed in the relation 
between the two groups and residual anxiety symptoms and between the five mindfulness 
facets and residual anxiety symptoms. Studies with a larger dataset are required before 
stronger conclusions can made about the association between mindfulness (facets) and anxiety 
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reduction. Nevertheless, the results of this study may have important implications for 
treatment of anxiety disorders. 
A second important limitation is that the main findings regarding the severity of 
anxiety symptoms and the level of mindfulness are based on self-report questionnaires which 
are sensitive to subjective biases. Because of the self-report measures, we could not be certain 
about whether the observed improvements are significant at a clinical level and whether they 
reflect the effect of MBCT on clinical symptomatology or if they are merely reflective of 
patients’ perceptions. Although self-report measures have been used in a variety of similar 
studies, it is important to acknowledge that patients’ reports are vulnerable to their 
perceptions and these measures may include inaccuracies.  
Third limitation is the lack of a follow up period due to time constraints. This study 
only looked at the effects of the MBCT course over the period of 8 weeks, so no conclusion 
can be drawn about the long-term effects. Future studies need to evaluate patients over longer 
period to determine if the positive clinical effects in this study are lasting. Segal, Williams & 
Teasdale (2002) assume that positive clinical effects in the MBCT group are contingent on 
whether patients acquire a practice of mindfulness skills. Future studies should therefore also 
focus on whether patients keep using the mindfulness skills after the group session are 
finished, and whether daily meditation leads to an ongoing decrease in anxiety symptoms and 
eventually stability.  
Fourth limitation is that the population of only anxiety patients may limit the 
generalizability of the result. Future research should investigate the effectiveness of MBCT in 
diverse patient populations with different clinical symptoms. 
Using a randomized controlled setting, this small-scaled study supported the 
promising results of MBCT for anxiety disorders (Hofmann, Sawyer, Witt & Oh, 2010; 
Miller, Flecther & Kabat-Zinn, 1995; Evans et al.,2008).  Significant results suggested that, 
despite the small sample, MBCT is a promising adjunct clinical intervention in treating 
residual anxiety symptoms. In addition, this study demonstrates that participating in the 
MBCT group leads to improved mindfulness facets. Also a strong trend was found between 
changes in the non-judging facet and decreased residual anxiety symptoms.  
In order to increase our understanding of MBCT as an adjunct clinical intervention 
future research is needed that includes better designed studies with larger number of patients, 
other patient populations and a longer follow up-period to determine if the positive outcomes 
of meditation practice are enduring. 
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